Clinical studies recruiting near Lancaster

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Lancaster General Hospital - Ann B Barshinger Cancer Institu · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · MUSC Health Lancaster Med Ctr · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The Centers for Advanced Urology d/b/a Keystone Urology Spec · Pfizer · NCT07028853 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Royal Lancaster Infirmary ( Site 3012) · Merck Sharp & Dohme LLC · NCT06136559 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Lancaster General Ann B Barshinger Cancer Institute · NRG Oncology · NCT05624996 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 131 · Locus Biosciences · NCT05488340 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Chemidox Clinical Trials Inc, Merz Investigational Site #001 · Merz Therapeutics GmbH · NCT07018700 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · City of Hope Antelope Valley · National Cancer Institute (NCI) · NCT05372614 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 8400001 · Sanofi · NCT06958536 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · OM Research LLC · Gilead Sciences · NCT06051617 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Keystone Urology Specialists · CG Oncology, Inc. · NCT06567743 A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Inmagene Site 1 · Inmagene LLC · NCT07037901 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Lancaster Radiation Therapy Center · NRG Oncology · NCT06532279 This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasm
Phase N/A · Chemidox Clinical Trials California · American Laboratory Products Company · NCT07089836 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · City of Hope Antelope Valley · NRG Oncology · NCT05174169 Persona Revision Knee System Outcomes
Phase N/A · Penn Medicine/ Lancaster General Health · Zimmer Biomet · NCT04821154 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Lancaster General Hospital · Bristol-Myers Squibb · NCT05489705 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Keystone Urology Specialists · Janssen Research & Development, LLC · NCT06319820 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · City Of Hope - Antelope Valley /ID# 263138 · AbbVie · NCT04928846 Pan Tumor Rollover Study
Phase 2 · Lancaster General Health · Bristol-Myers Squibb · NCT03899155 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · City of Hope Antelope Valley · Canadian Cancer Trials Group · NCT03550391 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · City of Hope Antelope Valley · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · City of Hope Antelope Valley · Canadian Cancer Trials Group · NCT06592924 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Lancaster General Hospital - Ann B Barshinger Cancer Institu · Bristol-Myers Squibb · NCT06561386 Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Phase N/A · Cardiology Care for Children · Tenaya Therapeutics · NCT05112237 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Keystone Urology Specialists · Dendreon · NCT06134232 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Lancaster General Ann B Barshinger Cancer Institute · NRG Oncology · NCT06748222 Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can
Phase 2 · City of Hope Antelope Valley · City of Hope Medical Center · NCT06954831 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557

Look up another city

Look up another condition